Yousif Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.25M Sell
4,244
-342
-7% -$97K 0.01% 936
2026
Q1
$1.28M Sell
4,586
-302
-6% -$87K 0.02% 909
2025
Q4
$1.53M Sell
4,888
-116
-2% -$36.2K 0.02% 852
2025
Q3
$1.4M Sell
5,004
-522
-9% -$142K 0.02% 916
2025
Q2
$1.33M Sell
5,526
-326
-6% -$77.1K 0.01% 968
2025
Q1
$1.43M Sell
5,852
-161
-3% -$48.4K 0.02% 905
2024
Q4
$1.98M Sell
6,013
-236
-4% -$80.1K 0.02% 765
2024
Q3
$2.09M Buy
6,249
+3,675
+143% +$1.17M 0.02% 748
2024
Q2
$703K Sell
2,574
-67
-3% -$19.5K 0.01% 1314
2024
Q1
$913K Sell
2,641
-134
-5% -$44.1K 0.01% 1239
2023
Q4
$896K Buy
2,775
+51
+2% +$16K 0.01% 1275
2023
Q3
$976K Sell
2,724
-122
-4% -$47.1K 0.01% 1156
2023
Q2
$1.08M Buy
2,846
+145
+5% +$59K 0.01% 1108
2023
Q1
$1.29M Sell
2,701
-207
-7% -$96.9K 0.02% 1010
2022
Q4
$1.22M Buy
2,908
+139
+5% +$56.1K 0.02% 1059
2022
Q3
$1.16M Sell
2,769
-29
-1% -$14.5K 0.02% 1106
2022
Q2
$1.39M Sell
2,798
-197
-7% -$103K 0.02% 1043
2022
Q1
$1.69M Buy
2,995
+10
+0.3% +$6.03K 0.02% 1057
2021
Q4
$2.25M Buy
+2,985
New +$2.23M 0.02% 891

Other funds holding BIO

Yousif Capital Management's BIO Position: Q2 2026 in Review

Yousif Capital Management reduced its Bio-Rad Laboratories Class A (BIO) stake by 7.5% in Q2 2026, selling an estimated $97K and leaving 4,244 shares worth $1.25M. The position accounts for 0.01% of the portfolio, ranked #936.

Yousif Capital Management first reported a position in BIO in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.25M in Q4 2021. 400 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • Yousif Capital Management held 4,244 shares of Bio-Rad Laboratories Class A worth $1.25M as of Q2 2026.
  • Yousif Capital Management sold 342 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $97K.
  • Bio-Rad Laboratories Class A made up 0.01% of Yousif Capital Management's portfolio in Q2 2026, its #936 holding.
  • Yousif Capital Management first reported a position in Bio-Rad Laboratories Class A in Q4 2021 and has held it in 19 quarters since.
  • Yousif Capital Management's Bio-Rad Laboratories Class A position peaked at $2.25M in Q4 2021.
  • 400 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Yousif Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.